Arul M. Chinnaiyan

Howard Hughes Medical Institute

Full Professor(heuristic)

Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine

h-index146

i10-index480

Publications1,730

Citations99,018

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 305

Data from: The melanocytic transcriptomic state independently associates with poor survival in long term follow up of metastatic melanoma patients
Zenodo (CERN European Organization for Nuclear Research) · 2026-06-22
Data from: The melanocytic transcriptomic state independently associates with poor survival in long term follow up of metastatic melanoma patients
Zenodo (CERN European Organization for Nuclear Research) · 2026-06-22
Genomic Determinants of Lethality and Therapeutic Vulnerability in Castration-Resistant Prostate Cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-20
Supplementary Figure S2 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Figure S11 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
2026-06-17
Supplementary Table S6 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Supplementary Figure S9 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Supplementary Figure S6 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Supplementary Table S2 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Figure S6 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
2026-06-17
Supplementary Figure S10 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Supplementary Figure S1 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Supplementary Table S1 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Figure S1 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
2026-06-17
Figure S9 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
2026-06-17
Figure S4 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
2026-06-17
Supplementary Table S5 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Supplementary Table S4 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Supplementary Figure S7 from The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
2026-06-17
Figure S2 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
2026-06-17

Open author page on OpenAlex →